VF
IDXG

Virtu Financial’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Virtu Financial’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,868
Closed -$55K – 1802
2020
Q2 		$55K Buy
+11,868
New +$61.5K 0.01% 994
2019
Q4 		$43K Buy
+8,626
New +$55.8K ﹤0.01% 1224
2019
Q3 		– Sell
-3,168
Closed -$23K – 2033
2019
Q2 		$23K Buy
3,168
+2,123
+203% +$15.5K ﹤0.01% 1334
2019
Q1 		$8K Sell
1,045
-7,859
-88% -$73.9K ﹤0.01% 1349
2018
Q4 		$71K Buy
8,904
+1,385
+18% +$16.6K 0.01% 1217
2018
Q3 		$116K Buy
+7,519
New +$90.6K 0.01% 1170
2018
Q1 		– Sell
-13,087
Closed -$133K – 2943
2017
Q4 		$133K Buy
+13,087
New +$158K 0.01% 1828

Other funds holding IDXG

SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $46.5B AUM 20.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return